CANF - Can-Fite BioPharma Ltd.
4.6
-1.420 -30.870%
Share volume: 1,008,615
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$6.02
-1.42
-0.24%
Summary score
22%
Profitability
25%
Dept financing
12%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-51.06%
Return on assets
-22.54%
Return on sales
0%
Return on invested capital
137.53%
Total debt ratio
53.04%
Debt ratio change over timeo
0%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
3.09%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-94.48%
Return on assets
-36.27%
Return on sales
0%
Return on invested capital
203.65%
Total debt ratio
54%
Debt ratio change over timeo
0%
Current Ratio
3.07%
Quick Ratio
0%
Cash Position Ratio
1.69%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-99.93%
Return on assets
-43.49%
Return on sales
0%
Return on invested capital
433.71%
Total debt ratio
48.53%
Debt ratio change over time
0%
Current Ratio
3.45%
Quick Ratio
0%
Cash Position Ratio
2.33%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CANF | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -51.06% | 16.32% | 4.62% | -0.95% |
| Return on assets | -22.54% | 3.37% | 3.4% | 3.77% |
| Return on sales | 0% | 23.81% | 26.22% | 33.63% |
| Return on invested capital | 137.53% | 4.94% | 4.34% | 5.38% |
| Profitability | 25% | 66% | 50% | 51% |
| Total debt ratio | 53.04% | 76.12% | 57.49% | 101.27% |
| Debt ratio change over time | 0% | 0% | 10.95% | 76.91% |
| Dept financing | 13% | 19% | 18% | 50% |
| Current Ratio | 3.07% | 1.14% | 1.29% | 2.09% |
| Quick Ratio | 0% | 0.88% | 1.02% | 1.98% |
| Cash Position Ratio | 1.69% | 0.17% | 0.52% | 1.5% |
| Liquididy | 50% | 28% | 38% | 40% |
| Short-term ratios | CANF | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -94.48% | 47.37% | 7.11% | -26.47% |
| Return on assets | -36.27% | 4% | 3.45% | 4.51% |
| Return on sales | 0% | 27.25% | 25.98% | 37.94% |
| Return on invested capital | 203.65% | 9.88% | 5.48% | 9.05% |
| Profitability | 25% | 66% | 41% | 51% |
| Total debt ratio | 54% | 92.44% | 61.53% | 111.53% |
| Debt ratio change over time | 0% | 0% | 14.12% | 17.59% |
| Dept financing | 12% | 21% | 34% | 50% |
| Current Ratio | 3.07% | 1.14% | 1.29% | 2.09% |
| Quick Ratio | 0% | 0.88% | 1.02% | 1.98% |
| Cash Position Ratio | 1.69% | 0.17% | 0.52% | 1.5% |
| Liquididy | 50% | 23% | 31% | 64% |